Which trial do we need? A pragmatic randomized trial of trimethoprim-sulfamethoxazole vs. vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia in low-resource settings

Simple item page
dc.contributor.authorRecht J.
dc.contributor.authorEvans T.J.
dc.contributor.authorChansamouth V.
dc.contributor.authorPhommasone K.
dc.contributor.authorMayxay M.
dc.contributor.authorAshley E.A.
dc.contributor.correspondenceRecht J.
dc.contributor.otherMahidol University
dc.date.accessioned2024-08-29T18:07:23Z
dc.date.available2024-08-29T18:07:23Z
dc.date.issued2024-01-01
dc.identifier.citationClinical Microbiology and Infection (2024)
dc.identifier.doi10.1016/j.cmi.2024.07.018
dc.identifier.eissn14690691
dc.identifier.issn1198743X
dc.identifier.pmid39067512
dc.identifier.scopus2-s2.0-85201579399
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/100625
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleWhich trial do we need? A pragmatic randomized trial of trimethoprim-sulfamethoxazole vs. vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia in low-resource settings
dc.typeNote
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85201579399&origin=inward
oaire.citation.titleClinical Microbiology and Infection
oairecerif.author.affiliationMahidol Oxford Tropical Medicine Research Unit
oairecerif.author.affiliationMinistry of Health Laos
oairecerif.author.affiliationMahosot Hospital, Lao
oairecerif.author.affiliationNuffield Department of Medicine

Files

Collections

Scopus 2024